FGF2 and depressive symptom measurement: A recent study measured serum FGF2 levels in the 28 MDD patients before and after treatment and 30 healthy controls using enzyme-linked immunosorbent assay, and found that serum FGF2 levels in patients with depression were significantly lower than those in healthy controls [46], consistent to our result.